Waters Sales and Earnings Rise, Despite Downturn in Mass Spec Sales for Proteomics | GenomeWeb

NEW YORK, Jan. 29 (GenomeWeb News) - Waters reported increased revenues and earnings for the fourth quarter of 2003 today, despite slow mass spec sales for proteomics.


The company's fourth quarter revenues increased to $275.1 million, from $256.4 million a year ago.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.